FDA inspection
Pfizer Manufacturing Belgium NV: FDA inspection ending Nov 16, 2017
FDA inspection 1036703 · No Action Indicated (NAI) · Puurs-Sint-Amands
Key facts
| Inspection ID | 1036703 |
|---|---|
| Firm | Pfizer Manufacturing Belgium NV |
| FEI number | 1000654629 |
| Address | Rijksweg 12 |
| City | Puurs-Sint-Amands |
| Country | Belgium |
| Fiscal year | 2018 |
| Inspection end date | Nov 16, 2017 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data